C. Mark Schneyer

Affiliations

  • Evp, Chief Financial Officer at Acadia Pharmaceuticals Inc (ACAD), 2024-04-09
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ACAD $17.87 2,716 28,742 2024-04-08 Filing
ACAD $17.90 5,434 26,183 2024-03-27 Filing
ACAD $24.67 772 21,067 2024-02-26 Filing
ACAD $22.64 5,108 Officer 20,486 2023-11-20 Filing
ACAD $29.00 10,000 Officer 15,682 2023-08-21 Filing